The Acusera Liquid Immunoassay Control is designed to be both easy and convenient to use and eliminates the need for reconstitution thus reducing the amount of human handling necessary and the subsequent risk of pipetting errors.

The recent inclusion of fully assayed target values and ranges for over 40 analytes enables laboratories to reduce the number of controls used and ultimately reduce costs and accurately assigned assayed target values are even provided for most immunoassay analyzers.

The combination of routine immunoassay analytes and a wide range of therapeutic drugs in a single liquid control material allows for increased efficiency across several areas of the clinical laboratory. As a true third party control, an unbiased, independent assessment of performance is guaranteed. Third Party is the term used to describe a control that has not been designed or optimized for use with a specific test or system. As such, they mirror the performance of patient samples and provide an unbiased, independent assessment of analytical performance.

The material is 100% human in origin providing a matrix similar to the patient sample but also reducing antibody interference and the possibility of control values shifting after changing reagent batch. Three clinically significant levels of control are available, supplied either separately or in a convenient and cost effective tri-level pack. A 5 mL vial size and open vial stability of seven days at 2-8 °C minimizes waste and helps to keep costs low.

The Acusera Liquid Immunoassay Control (Randox Laboratories Ltd; Crumlin, UK) is compatible for use with Acusera 24.7, a web based interlaboratory data management program. Users of Acusera 24.7 benefit from optimum performance and gain access to peer group data from laboratories worldwide. Peer group data is uniquely updated every 24 hours giving access to the most up to date information available.

Related Links:
Randox Laboratories Ltd.